Wooree Bio Co.Ltd (082850) - Net Assets

Latest as of December 2025: ₩261.34 Billion KRW ≈ $177.11 Million USD

Based on the latest financial reports, Wooree Bio Co.Ltd (082850) has net assets worth ₩261.34 Billion KRW (≈ $177.11 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩761.92 Billion ≈ $516.34 Million USD) and total liabilities (₩500.57 Billion ≈ $339.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Wooree Bio Co.Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩261.34 Billion
% of Total Assets	34.3%
Annual Growth Rate	3.86%
5-Year Change	68.67%
10-Year Change	102.58%
Growth Volatility	25.36

Wooree Bio Co.Ltd - Net Assets Trend (2008–2025)

This chart illustrates how Wooree Bio Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Wooree Bio Co.Ltd asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Wooree Bio Co.Ltd (2008–2025)

The table below shows the annual net assets of Wooree Bio Co.Ltd from 2008 to 2025. For live valuation and market cap data, see market cap of Wooree Bio Co.Ltd.

Year	Net Assets	Change
2025-12-31	₩261.34 Billion ≈ $177.11 Million	+23.20%
2024-12-31	₩212.13 Billion ≈ $143.76 Million	-15.52%
2023-12-31	₩251.10 Billion ≈ $170.17 Million	+40.27%
2022-12-31	₩179.01 Billion ≈ $121.32 Million	+15.54%
2021-12-31	₩154.94 Billion ≈ $105.00 Million	+39.40%
2020-12-31	₩111.15 Billion ≈ $75.32 Million	+19.06%
2019-12-31	₩93.36 Billion ≈ $63.27 Million	+6.09%
2018-12-31	₩88.00 Billion ≈ $59.64 Million	-32.29%
2017-12-31	₩129.96 Billion ≈ $88.08 Million	+0.74%
2016-12-31	₩129.01 Billion ≈ $87.43 Million	+1.67%
2015-12-31	₩126.89 Billion ≈ $85.99 Million	-48.93%
2014-12-31	₩248.46 Billion ≈ $168.38 Million	-11.90%
2013-12-31	₩282.03 Billion ≈ $191.13 Million	+28.97%
2012-12-31	₩218.68 Billion ≈ $148.20 Million	-2.51%
2011-12-31	₩224.31 Billion ≈ $152.01 Million	-9.43%
2010-12-31	₩247.65 Billion ≈ $167.83 Million	+22.81%
2009-12-31	₩201.66 Billion ≈ $136.66 Million	+47.00%
2008-12-31	₩137.18 Billion ≈ $92.97 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Wooree Bio Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 7201786367000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩72.02 Billion	35.17%
Other Components	₩132.73 Billion	64.83%
Total Equity	₩204.75 Billion	100.00%

Wooree Bio Co.Ltd Competitors by Market Cap

The table below lists competitors of Wooree Bio Co.Ltd ranked by their market capitalization.

Company	Market Cap
Urja Global Limited NSE:URJA	$64.95 Million
Catalyst Bancorp Inc NASDAQ:CLST	$64.99 Million
Kukje Pharma Co Ltd KO:002720	$65.00 Million
Everest Industries Limited NSE:EVERESTIND	$65.00 Million
Linc Limited NSE:LINC	$64.90 Million
Gedeon Richter PLC LSE:0QFP	$64.85 Million
Kazia Therapeutics Ltd ADR NASDAQ:KZIA	$64.84 Million
GameSparcs Co Ltd TWO:6542	$64.84 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Wooree Bio Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 212,131,592,010 to 204,750,213,610, a change of -7,381,378,400 (-3.5%).
Net loss of 9,374,160,240 reduced equity.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-9.37 Billion	-4.58%
Other Changes	₩1.99 Billion	+0.97%
Total Change	₩-	-3.48%

Book Value vs Market Value Analysis

This analysis compares Wooree Bio Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.52x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.70x to 0.52x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩3203.66	₩2240.00	x
2017-12-31	₩3227.38	₩2240.00	x
2018-12-31	₩2185.26	₩2240.00	x
2019-12-31	₩2137.86	₩2240.00	x
2020-12-31	₩2545.28	₩2240.00	x
2021-12-31	₩3386.89	₩2240.00	x
2022-12-31	₩3829.41	₩2240.00	x
2023-12-31	₩4227.12	₩2240.00	x
2024-12-31	₩4493.61	₩2240.00	x
2025-12-31	₩4337.25	₩2240.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Wooree Bio Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -4.58%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -0.90%
• Asset Turnover: 1.37x
• Equity Multiplier: 3.72x
Recent ROE (-4.58%) is below the historical average (-1.20%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	16.33%	3.85%	1.30x	3.27x	₩7.77 Billion
2009	17.41%	3.38%	1.72x	3.00x	₩13.85 Billion
2010	5.32%	0.72%	1.96x	3.77x	₩-9.07 Billion
2011	3.44%	2.01%	0.83x	2.07x	₩-13.05 Billion
2014	-19.86%	-2.24%	1.63x	5.43x	₩-44.06 Billion
2015	-22.77%	-1.64%	1.94x	7.17x	₩-41.58 Billion
2016	-31.16%	-2.62%	1.88x	6.34x	₩-53.10 Billion
2017	-9.59%	-0.85%	2.40x	4.72x	₩-25.46 Billion
2018	-37.37%	-2.57%	2.11x	6.88x	₩-41.69 Billion
2019	4.85%	0.27%	2.74x	6.53x	₩-4.80 Billion
2020	15.15%	1.04%	2.51x	5.81x	₩5.73 Billion
2021	21.40%	2.15%	2.32x	4.29x	₩17.66 Billion
2022	12.19%	1.61%	2.42x	3.12x	₩3.92 Billion
2023	7.81%	1.23%	2.16x	2.94x	₩-4.37 Billion
2024	2.24%	0.38%	2.03x	2.87x	₩-16.47 Billion
2025	-4.58%	-0.90%	1.37x	3.72x	₩-29.85 Billion

Industry Comparison

This section compares Wooree Bio Co.Ltd's net assets metrics with peer companies in the Semiconductors & Semiconductor Equipment industry.

Industry Context

Industry: Semiconductors & Semiconductor Equipment
Average net assets among peers: $155,102,758,089
Average return on equity (ROE) among peers: 7.06%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Wooree Bio Co.Ltd (082850)	₩261.34 Billion	16.33%	1.92x	$64.91 Million
PSK HOLDINGS Inc (031980)	$197.51 Billion	29.97%	0.21x	$459.89 Million
Fidelix Co. Ltd (032580)	$34.90 Billion	13.90%	0.69x	$22.13 Million
Cloud Air Co.Ltd (036170)	$63.80 Billion	0.95%	0.08x	$148.12 Million
UNISEM Co. Ltd (036200)	$228.30 Billion	6.80%	0.15x	$225.30 Million
JUSUNG ENGINEERING Co. Ltd (036930)	$514.75 Billion	6.61%	0.56x	$4.12 Billion
Lumens Co. Ltd (038060)	$221.56 Billion	-2.75%	0.53x	$37.16 Million
iA Inc (038880)	$24.15 Billion	0.00%	1.77x	$149.31 Million
meerecompany Incorporated (049950)	$98.85 Billion	28.50%	0.67x	$79.45 Million
I&C Technology Co. Ltd (052860)	$56.05 Billion	-26.42%	0.28x	$66.41 Million
KMH Hitech Co. Ltd (052900)	$111.17 Billion	13.01%	0.69x	$37.41 Million

About Wooree Bio Co.Ltd

KQ:082850 Korea Semiconductors & Semiconductor Equipment

Market Cap

$64.91 Million

₩95.78 Billion KRW

Market Cap Rank

#20873 Global

#1280 in Korea

Share Price

₩2240.00

Change (1 day)

+0.90%

52-Week Range

₩1542.00 - ₩2570.00

All Time High

₩9310.00